Yahoo Web Search

Search results

    • Merck to Acquire EyeBio

      Morningstar· 11 hours ago

      Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the ...

    • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 7 days ago

      SystImmune, Inc. Announces Transition of Chief Medical Officer PR Newswire REDMOND, Wash., May 23, 2024 REDMOND, Wash., May 23, 2024 /PRNewswire/ -- SystImmune, Inc., a pioneering clinical-stage biopharmaceutical company focused on developing novel